Pneumococcal Serotype-Specific Antibodies Persist through Early Childhood after Infant Immunization: Follow-Up from a Randomized Controlled Trial

• Johannes Trück ,

  * E-mail: johannes.truck@paediatrics.ox.ac.uk

  Affiliation Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre, Oxford, United Kingdom

  ⨯
• Matthew D. Snape,

  Affiliation Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre, Oxford, United Kingdom

  ⨯
• Florencia Tatangeli,

  Affiliation Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre, Oxford, United Kingdom

  ⨯
• Merryn Voysey,

  Affiliation Centre for Statistics in Medicine, University of Oxford, Oxford, United Kingdom

  ⨯
• Ly-Mee Yu,

  Affiliation Centre for Statistics in Medicine, University of Oxford, Oxford, United Kingdom

  ⨯
• Saul N. Faust,

  Affiliation NIHR Wellcome Trust Clinical Research Facility and NIHR Respiratory Biomedical Research Unit, University Hospital Southampton NHS Foundations Trust and Faculty of Medicine and Institute for Life Sciences, University of Southampton, Southampton, United Kingdom

  ⨯
• Paul T. Heath,

  Affiliation St. George’s Vaccine Institute, St. George’s, University of London, London, United Kingdom

  ⨯
• Adam Finn,

  Affiliation Bristol Children’s Vaccine Centre, University Hospitals Bristol NHS Foundation Trust and University of Bristol, Bristol, United Kingdom

  ⨯
• Andrew J. Pollard

  Affiliation Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre, Oxford, United Kingdom

  ⨯